PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

11 integrated health systems form largest private-sector diabetes registry in US

2012-06-08
(PORTLAND, Ore.) —June 07, 2012—Eleven integrated health systems, with more than 16 million members, have combined de-identified data from their electronic health records to form the largest, most comprehensive private-sector diabetes registry in the nation. According to a new study published today in the Centers for Disease Control and Prevention's Preventing Chronic Disease, the SUPREME-DM DataLink provides a unique and powerful resource to conduct population-based diabetes research and clinical trials. "The DataLink will allow us to compare more prevention and ...

U Alberta finds weakness in armor of killer hospital bacteria

2012-06-08
There's new hope for development of an antibiotic that can put down a lethal bacteria or superbug linked to the deaths of hundreds of hospital patients around the world. Researchers from the University of Alberta-based Alberta Glycomics Centre found a chink in the molecular armour of the pathogen Acinetobacter baumannii. The bacteria first appeared in the 1970's and in the last decade it developed a resistance to most antibiotics. U of A microbiologist Mario Feldman identified a mechanism that allows Acinetobacter baumannii to cover its surface with molecules knows ...

Personalizing biologic treatment to individual patients with rheuatoid arthritis is cost-effective

2012-06-08
Berlin, Germany, June 7 2012: Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tailoring biologic treatment to individual patients with rheumatoid arthritis (RA) can reduce total costs by €2,595,557 per 272 patients over 3 years (95 percentile range -€2,983,760 to -€2,211,755), whilst increasing effectiveness by an average of 3.67 quality-adjusted life years (QALYs)*. Cost savings were mostly on drug costs. The Dutch study, which investigated 272 patients with RA starting adalimumab treatment, measured ...

Treatment with anti-TNFs reduces the risk of cardiovascular events in rheumatoid arthritis

2012-06-08
Berlin, Germany, June 7 2012: Results from a retrospective analysis of contemporary data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, predict, based on estimates from a multivariate regression model, that the cumulative use of anti-tumour necrosis factor drugs (anti-TNFs) for one, two, or three years is associated with reduced risk of cardiovascular events by 24%, 42% and 56% in patients with rheumatoid arthritis (RA) respectively, compared to not using anti-TNF therapies (adjusting for background use of methotrexate or other ...

Nearly two-thirds of American osteoporotic hip fractures are seen in the extreme elderly

2012-06-08
Berlin, Germany, June 7 2012: A new American study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, calls for more aggressive management of osteoporosis in the extreme elderly as the true impact of osteoporotic hip fractures in those aged 80 years or older is unveiled. Via the Nationwide Inpatient Sample (NIS), 4.3 million patients over the age of 65 with osteoporotic hip fractures were studied. Results showed that 67.3% of hip fractures occurred in the extreme elderly, increasing from 172,209 in 1993 to 180,428 in 2008. This ...

Patients taking certolizumab pegol are twice as likely to achievE ACR20 compared to placebo

2012-06-08
Berlin, Germany, June 7 2012: A new Phase III study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that patients treated with certolizumab pegol (CZP) were twice as likely to meet the primary endpoint of ACR20* response at week 12 than those on placebo: 58% on CZP200mg Q2W; and 51.9% on CZP 400 mg Q4W compared to 24.3% on placebo. This randomised, placebo controlled, 24 week period of an ongoing Phase III study of 409 patients indicated that more patients treated with both doses of CZP achieved ACR50* and ACR70* response ...

Control of disease activity and biologic treatment increase life expectency in RA patients

2012-06-08
Berlin, Germany, June 7 2012: According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with rheumatoid arthritis (RA) who are prescribed biologic treatments have a significantly lower mortality risk (adjusted hazard ratio [HR]: 0.61) than those just treated with traditional disease modifying anti-rheumatic drugs (DMARDs).The study also found the mortality was similar irrespective of the method of action of biologics (anti-tumour necrosis factor drugs [anti-TNFs] or rituximab). Results of the German study ...

Treatment with anti-TNFs can increase the risk of shingles by up to 75 percent

2012-06-08
Berlin, Germany, June 7 2012: Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism. "Anti-TNFs, such as infliximab, adalimumab and etanercept have become the treatment of choice for patients with inflammatory rheumatic diseases who ...

Head-to-head study in RA shows that abatacept has comparable efficacy to adalimumab

2012-06-08
Berlin, Germany, June 7 2012: Data from one of the few head-to-head trials in rheumatoid arthritis (RA) presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that at one year, 64.8% of patients receiving abatacept (Orencia) and 63.4% of patients receiving adalimumab (Humira) achieved ACR20*. The Phase IIIb AMPLE study (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) was carried out in 646 biologic-naïve patients with active RA and inadequate response to methotrexate. ...

Experts call for strong regulation and peer review of military and civilian nuclear programs

Experts call for strong regulation and peer review of military and civilian nuclear programs
2012-06-08
All nuclear energy and weapons programs should be independently regulated and subject to rigorous peer review, according to three experts on nuclear policy. Their comments and recommendations are published in an article entitled, "A Safer Nuclear Enterprise," in the June 8 issue of the journal Science. The authors noted that, despite international diplomatic efforts to prevent the proliferation of nuclear weapons and ensure that nuclear material is protected against theft, there is growing apprehension about terrorists acquiring weapons or nuclear material. "There is ...

CheapCarInsurance.net Explains Why You Should Purchase Rental Car Insurance

2012-06-08
When you are planning a vacation or a trip and you need to rent a car, one of the most important things that you should consider is whether or not you need to buy rental car insurance. When you search for a car rental company online or in person, most salespeople will tell you that you need insurance, while most web pages will tell you that you do not need it. This couldn't be further from the truth. In reality, purchasing rental car insurance for a few extra dollars per day may be one of the most intelligent things that a person can do for themselves. CheapCarInsurance.net ...

CU-Boulder physicists use ultrafast lasers to create first tabletop X-ray device

2012-06-08
An international research team led by the University of Colorado Boulder has generated the first laser-like beams of X-rays from a tabletop device, paving the way for major advances in many fields including medicine, biology and nanotechnology development. For half a century, scientists have been trying to figure out how to build a cost-effective and reasonably sized X-ray laser that could, among other things, provide super-high-resolution imaging, according to Henry Kapteyn, a CU-Boulder physics professor and fellow at JILA, a joint institute of CU-Boulder and the National ...

New brain target for appetite control identified

2012-06-08
New York, NY (June 7, 2012) — Researchers at Columbia University Medical Center (CUMC) have identified a brain receptor that appears to play a central role in regulating appetite. The findings, published today in the online edition of Cell, could lead to new drugs for preventing or treating obesity. "We've identified a receptor that is intimately involved in regulating food intake," said study leader Domenico Accili, MD, professor of Medicine at CUMC. "What is especially encouraging is that this receptor is belongs to a class of receptors that turn out to be good targets ...

New twist on old chemical process could boost energy efficiency

New twist on old chemical process could boost energy efficiency
2012-06-08
Chemical reactions on the surface of metal oxides, such as titanium dioxide and zinc oxide, are important for applications such as solar cells that convert the sun's energy to electricity. Now University of Washington scientists have found that a previously unappreciated aspect of those reactions could be key in developing more efficient energy systems. Such systems could include, for example, solar cells that would produce more electricity from the sun's rays, or hydrogen fuel cells efficient enough for use in automobiles, said James Mayer, a UW chemistry professor. "As ...

Parasitic plants 'steal' genes from their hosts

Parasitic plants steal genes from their hosts
2012-06-08
New research published today in BioMed Central's open access journal BMC Genomics reveals that the Malaysian parasitic plant Rafflesia cantleyi, with its 50cm diameter flowers, has 'stolen' genes from its host Tetrastigma rafflesiae. Analysis of these genes shows that their functions range from respiration to metabolism, and that some of them have even replaced the parasites own gene activity. Vertical gene transfer is that between parents and their offspring, while horizontal gene transfer is the movement of genes between two different organisms. Bacteria use horizontal ...

Engineered robot interacts with live fish

2012-06-08
A bioinspired robot has provided the first experimental evidence that live zebrafish can be influenced by engineered robots. Results published today, 8 June, in IOP Publishing's journal Bioinspiration and Biomimetics, provide a stepping stone on the path to using autonomous robots in an open environment to monitor and control fish behaviour. In the future, water-based robots could potentially contribute to the protection of endangered animals and the control of pest species. The robot, created by researchers from Polytechnic Institute of New York University and ...

Manipulating chromatin loops to regulate genes may offer future treatments for blood diseases

Manipulating chromatin loops to regulate genes may offer future treatments for blood diseases
2012-06-08
In exploring how proteins interact with crucial DNA sequences to regulate gene activity, researchers have shed light on key biological events that may eventually be manipulated to provide new disease treatments. Within a cell's nucleus, regulatory elements in DNA called promoters and enhancers communicate with each other in carrying out gene activity, often over large genomic distances, hundreds of thousands of chemical bases apart from each other in chromosomes. As these elements physically contact each other, the intervening DNA sequences bend into loops made of chromatin ...

Immune system 'circuitry' that kills malaria in mosquitoes identified

2012-06-08
Researchers at the Johns Hopkins Malaria Research Institute have, for the first time, determined the function of a series proteins within the mosquito that transduce a signal that enables the mosquito to fight off infection from the parasite that causes malaria in humans. Together, these proteins are known as immune deficiency (Imd) pathway signal transducing factors, are analogous to an electrical circuit. As each factor is switched on or off it triggers or inhibits the next, finally leading to the launch of an immune response against the malaria parasite. The study was ...

Pre-existing problems

2012-06-08
In a critical step that may lead to more effective HIV treatments, Harvard scientists have found that, in a small number of HIV patients, pre-existing mutations in the virus can cause it to develop resistance to the drugs used to slow the progression of the disease. The finding is particularly important because, while researchers have long known HIV can develop resistance to some drugs, it wasn't understood whether the virus relied on pre-existing mutations to develop the resistance, or if it has to wait for those mutations to occur. By shedding new light on how resistance ...

Should spinal manipulation for neck pain be abandoned?

2012-06-08
The effectiveness of spinal manipulation divides medical opinion. On bmj.com today, experts debate whether spinal manipulation for neck pain should be abandoned. Spinal manipulation is a technique that involves the application of various types of thrusts to the lumbar spine (lower back) or cervical spine (neck) to reduce back pain, neck pain and other musculoskeletal conditions. Neil O'Connell and colleagues argue that cervical spine manipulation "may carry the potential for serious neurovascular complications" and that the technique is "unnecessary and inadvisable." ...

Patients suffering from pre-diabetes at potential future risk of stroke

2012-06-08
Millions of people suffering from pre-diabetes may be at a higher risk of stroke, a study published on bmj.com today suggests. Pre-diabetes is characterised by higher than normal blood glucose levels that, if left untreated, develops into type 2 diabetes. The scale of the problem is enormous and growing, with an estimated 79 million people in the US and 7 million people in the UK affected. People with pre-diabetes also harbour the same vascular risk factors as people with type 2 diabetes, such as high blood pressure, high cholesterol and obesity, but its effect on ...

By adding VSL#3 probiotic to traditional therapies UC patients can improve remission rates

2012-06-08
GAITHERSBURG, MD, June 7 – As one of the few probiotics with medical food designation for specific illnesses, VSL#3® has been the subject of a collection of more than 80 studies that have demonstrated its use in the dietary management of IBS, ulcerative colitis, and an ileal pouch. Ulcerative colitis patients, in particular, have been shown to benefit from adding VSL#3 medical food to their prescription drug regimen. One particular study shows that the combination of VSL#3 and traditional drug therapy can improve remission rates over drug therapy alone by 10 to 17 percent, ...

Haematopoietic stem cell transplantation increases survival in systemic sclerosis patients

2012-06-08
Berlin, Germany, June 7 2012: Initial results from an international, investigator-initiated, open label phase III trial were presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism. Data indicate that haematopoietic stem cell transplantation (HSCT) results in better long term survival than conventional treatment for patients with poor prognosis early diffuse cutaneous systemic sclerosis. The ASTIS (Autologous Stem Cell Transplantation International Scleroderma) trial enrolled more than 150 patients between 2001 and 2009, and randomised ...

Mapping genes: Mayo Clinic finds new risk factors for neurodegenerative diseases

2012-06-08
JACKSONVILLE, Fla. — Using a new and powerful approach to understand the origins of neurodegenerative disorders such as Alzheimer's disease, researchers at Mayo Clinic in Florida are building the case that these diseases are primarily caused by genes that are too active or not active enough, rather than by harmful gene mutations. In the June 7 online issue of PLoS Genetics, they report that several hundred genes within almost 800 brain samples of patients with Alzheimer's disease or other disorders had altered expression levels that did not result from neurodegeneration. ...

Surgeon experience affects complication rate of spinal stenosis surgery

2012-06-08
Philadelphia, Pa. (June 7, 2012) - For patients undergoing surgery for spinal stenosis, the risk of complications is higher when the surgeon performs very few such procedures—less than four per year, suggests a study in the June issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. In contrast, the complication rate is not significantly affected by the volume of spinal stenosis surgeries performed at the hospital, according to the new research. The senior ...
Previous
Site 6152 from 8514
Next
[1] ... [6144] [6145] [6146] [6147] [6148] [6149] [6150] [6151] 6152 [6153] [6154] [6155] [6156] [6157] [6158] [6159] [6160] ... [8514]

Press-News.org - Free Press Release Distribution service.